The latest report by IMARC Group, titled “Australia Medical Cannabis Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025–2033,” offers a comprehensive analysis of the Australia medical cannabis market growth. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry. The Australia medical cannabis market size reached USD 740 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,373.1 Million by 2033, exhibiting a growth rate (CAGR) of 7.10% during 2025–2033.
Report Attributes:
· Base Year: 2024
· Forecast Years: 2025–2033
· Historical Years: 2019–2024
· Market Size in 2024: USD 740 Million
· Market Forecast in 2033: USD 1,373.1 Million
· Market Growth Rate 2025–2033: 7.10%
For an in-depth analysis, you can refer to a sample copy of the report:
https://www.imarcgroup.com/australia-medical-cannabis-market/requestsample
Australia Medical Cannabis Market Overview
- Increasing government approvals and eased regulations are fostering market expansion.
- Rising patient demand for alternative treatments for chronic conditions is driving growth.
- Expansion of product offerings including oils, capsules, dried flowers, topicals, and sprays.
- Telehealth clinics facilitate access, particularly in rural and underserved regions.
- Growing physician acceptance and patient awareness are boosting demand.
- Domestic cultivation and import partnerships are scaling supply to meet needs.
- Regulatory compliance and pharmaceutical-grade quality standards ensure product trust.
Key Features and Trends of Australia Medical Cannabis Market
- Diversified product applications targeting cancer, epilepsy, arthritis, anxiety, and migraine.
- Increasing incorporation of high-THC and high-CBD formulations catering to various patient profiles.
- Advances in administration routes such as oral, vaporization, and topical applications.
- Growing telemedicine and online prescription platforms improving market access.
- Expansion of clinical research and trials supporting evidence-based use.
Growth Drivers of Australia Medical Cannabis Market
- Government support through TGA approvals and licensing frameworks.
- Rising prevalence of chronic diseases and unmet medical treatment needs.
- Enhanced healthcare infrastructure enabling broader patient reach.
- Expansion in clinician knowledge and patient education.
- Evolving regulatory environment facilitating market formalization.
Innovation & Market Demand of Australia Medical Cannabis Market
- Development of novel formulations and delivery systems for improved efficacy and compliance.
- Integration of technology-enabled patient monitoring and telehealth support.
- Growing use of Australian native cannabis strains and botanical extracts.
- Increasing investments in domestic production capabilities and quality control.
- Expansion of pharmacy kiosk initiatives and cross-border operations (e.g., New Zealand).
Australia Medical Cannabis Market Opportunities
- Expansion of product portfolios to cover broader therapeutic areas.
- Growth in telehealth services enhancing accessibility and prescriptions.
- Increasing collaboration between research institutions and industry players.
- Adoption of GMP standards and pharmaceutical-grade manufacturing.
- Development of patient-centric services and personalized medicine approaches.
Australia Medical Cannabis Market Challenges
- Complex and evolving regulatory landscape requiring compliance agility.
- High costs of clinical research and product development.
- Patient and provider education gaps leading to cautious adoption.
- Supply chain challenges including product consistency and availability.
- Persistent stigma and legal uncertainties affecting market confidence.
Australia Medical Cannabis Market Analysis
- New South Wales and Victoria dominate market revenue due to healthcare infrastructure.
- Regional expansion supports rural patient accessibility enhancement.
- Increasing patient diversity is prompting customized treatment protocols.
- Competitive landscape includes domestically cultivated and imported products.
- Regulatory milestones are closely tied to market growth and investor confidence.
Australia Medical Cannabis Market Segmentation:
By Product Type:
o Oils and Capsules
o Dried Flowers
o Topicals
o Sprays
By Species:
o Indica
o Sativa
o Hybrid
By Derivative:
o CBD (Cannabidiol)
o THC (Tetrahydrocannabinol)
o Others
By Application:
o Cancer
o Epilepsy
o Arthritis
o Anxiety
o Migraine
o Others
By End User:
o Pharmaceutical Companies
o Research Institutions
o Others
By Region:
o Australia Capital Territory & New South Wales
o Victoria & Tasmania
o Queensland
o Northern Territory & Southern Australia
o Western Australia
Australia Medical Cannabis Market News & Recent Developments:
- Dispensed has expanded operations to New Zealand using pharmacy kiosks, signaling regional growth and market confidence.
- Continuous regulatory updates by TGA supporting licensing and easier patient access.
Australia Medical Cannabis Market Key Players:
- Tilray Inc.
- Cann Group Limited
- AusCann Group Holdings Ltd
- Althea Group Holdings Ltd
- Elixinol Global Limited
- Medlab Clinical Limited
- Little Green Pharma
Key Highlights of the Report:
- Market Performance (2019–2024)
- Market Outlook (2025–2033)
- Regulatory Environment and Policies
- Product Innovation and Technology Trends
- Market Drivers and Success Factors
- Competitive Landscape
- Regional Market Dynamics
- Challenges and Barriers
- Strategic Recommendations
- Value Chain and Partnership Analysis
- Growth Opportunities
Note: If you need specific information that is not currently within the scope of the report, customization is available.
Ask analyst for your customized sample: https://www.imarcgroup.com/request?type=report&id=32011&flag=E
FAQs: Australia Medical Cannabis Market
Q1: What is the forecasted market size of the Australia medical cannabis market by 2033?
A: The market is projected to reach USD 1,373.1 Million by 2033.
Q2: What are the primary product types in the Australia medical cannabis market?
A: Oils & capsules, dried flowers, topicals, and sprays.
Q3: Which therapeutic applications drive market growth?
A: Cancer, epilepsy, arthritis, anxiety, migraine, and others.
Q4: What are the key growth drivers?
A: Government approvals, rising patient demand, expanded product offerings, telehealth services, and growing physician acceptance.
Q5: Who are the major players operating in the Australia medical cannabis market?
A: Tilray, Cann Group, AusCann, Althea Group, Elixinol, Medlab Clinical, and Little Green Pharma.
About Us:
IMARC Group is a leading market research company providing management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our solutions include comprehensive market intelligence, custom consulting, and actionable insights to help organizations make informed decisions and achieve sustainable growth.
Contact Us: 134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No: (D) +91 120 433 0800
United States: +1-201971-6302
Comments